Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT06780358

Study of bladdeR Cancer Detection in Standard White Light Versus AI-Supported Endoscopy-02

Status
Enrolling By Invitation
Phase
N/A
Study type
Interventional
Enrollment
64 (estimated)
Sponsor
Cystotech · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study is being conducted to investigate if an artificial intelligence support tool is non-inferior in detecting bladder cancer compared to the traditional method, standard white light cystoscopy (WLC). The researchers will compare how well the artificial intelligence tool and WLC perform in detecting bladder cancer through a controlled, organized testing process.

Detailed description

This clinical investigation aims to confirm that an artificial intelligence model utilizing a Convolutional Neural Network (CNN) can achieve sensitivity in detecting bladder cancer that is non-inferior to traditional white light cystoscopy (WLC) in a randomized controlled trial. The investigational artificial intelligence device leverages the advanced capabilities of CNNs, a type of deep learning model designed to analyze visual imagery with high precision.

Conditions

Interventions

TypeNameDescription
DEVICEAI supported detection of bladder cancerAI-model-supported detection of bladder cancer during white light cystoscopy

Timeline

Start date
2024-11-20
Primary completion
2025-04-01
Completion
2025-05-01
First posted
2025-01-17
Last updated
2025-01-17

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT06780358. Inclusion in this directory is not an endorsement.